Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 81

This Paper With 20 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-18-4_011

تاریخ نمایه سازی: 23 آبان 1402

Abstract:

Background & Objective: Acute Promyelocytic Leukemia (APL) is a medical emergency with potentially fatal complications. APL primarily results from a chromosomal translocation (t(۱۵;۱۷)(q۲۲;q۲۱)), leading to the formation of the PML-RARA fusion gene with three possible isoforms. This study aims to investigate the characteristics of Iranian APL patients, the distribution of PML-RARA isoforms, and survival analysis.Methods: We included ۱۴۵ consecutive eligible patients in this study. Data were collected through archived documents and phone inquiries, following consent. Subsequently, we analyzed the data using SPSS software version ۲۶.۰.Results: We examined ۷۵ men and ۷۰ women, with a mean age of ۳۴ years (range: ۲-۷۸ years). Besides t(۱۵;۱۷) (q۲۲;q۲۱), ۴۵.۶% had other chromosomal abnormalities. The prevalence of bcr۱ and bcr۳ isoforms was ۷۳% and ۲۷%, respectively. bcr۳ correlated with higher white blood cell (WBC) counts, additional chromosomal abnormalities, and faster Complete Hematologic Response (CHR). Early death occurred in approximately ۳۶% of all patients. The mean overall survival time was ۷۳.۵ months, with ۱۲۰-month survival rates of ۵۳.۸% for all patients and ۸۳.۹% for those who achieved CHR. Univariate analysis identified old age, relapse, lower platelet (PLT) counts, higher WBC counts, and leukocytosis as survival risk factors. However, in multivariate analysis, only old age and higher WBC counts were identified as adverse prognostic factors.Conclusion: In Iranian APL patients, bcr۱ predominates, while bcr۳ correlates with higher WBC counts, high-risk categorization, additional chromosomal abnormalities, and faster CHR. Survival is negatively impacted by old age, relapse, lower PLT counts, higher WBC counts, and leukocytosis.

Authors

Sarah Siahbani

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Akbar Safaie

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Masoumeh Faghih

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Marzieh Hosseini

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Afsaneh Fendereski

Department of Biostatistics, School of Health, Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Behnaz Valibeigi

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Ahmad Monabati

Molecular Pathology and Cytogenetic Ward, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Chatterjee T, Gupta S, Sharma S, Ganguli P. Distribution of ...
  • Mantha S, Goldman DA, Devlin SM, Lee J-W, Zannino D, ...
  • Pandolfi P, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, ...
  • Gonzalez M, Barragan E, Bolufer P, Chillon C, Colomer D, ...
  • Sučić M, Zadro R, Burazer B, Labar B, Nemet D, ...
  • society Ac. Treatment of Acute Promyelocytic Leukemia (APL) [webpage]. American ...
  • [Guideline] National Comprehensive Cancer Network. Acute Myeloid Leukemia. NCCN. Available ...
  • Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, ...
  • Gabert J, Beillard E, Van der Velden V, Bi W, ...
  • Melo CPS, Campos CB, Dutra ÁP, Neto JCA, Fenelon AJS, ...
  • Ayatollahi H, Bazi A, Sadeghian MH, Fani A, Siyadat P, ...
  • Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, ...
  • Chen Y, Kantarjian H, Wang H, Cortes J, Ravandi F. ...
  • Greenlee RT, Hill‐Harmon MB, Murray T, Thun M. Cancer statistics, ...
  • McClellan JS, Kohrt HE, Coutre S, Gotlib JR, Majeti R, ...
  • Testa U, Lo-Coco F. Prognostic factors in acute promyelocytic leukemia: ...
  • Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, ...
  • نمایش کامل مراجع